Literature DB >> 14595559

Transformation of myocarditis and inflammatory cardiomyopathy to idiopathic dilated cardiomyopathy: facts and fiction.

Hans R Figulla1.   

Abstract

There is broad evidence that enteroviruses and adenoviruses can induce an acute inflammation of the myocardium without cardiac dysfunction (i.e. myocarditis) or with cardiac dysfunction (i.e. inflammatory cardiomyopathy) that can transform to a virus-negative dilated cardiomyopathy. In the adult patient neither other viruses (parvo-B 19 virus, hepatitis C virus, cytomegalovirus) nor post-infection autoimmunity are likely to induce idiopathic dilated cardiomyopathy.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14595559     DOI: 10.1007/s00430-003-0205-y

Source DB:  PubMed          Journal:  Med Microbiol Immunol        ISSN: 0300-8584            Impact factor:   3.402


  10 in total

Review 1.  Postviral autoimmune heart disease--fact or fiction?

Authors:  A L Caforio; C Baboonian; W J McKenna
Journal:  Eur Heart J       Date:  1997-07       Impact factor: 29.983

2.  A prospective, randomized, controlled trial of prednisone for dilated cardiomyopathy.

Authors:  J E Parrillo; R E Cunnion; S E Epstein; M M Parker; A F Suffredini; M Brenner; G L Schaer; S T Palmeri; R O Cannon; D Alling
Journal:  N Engl J Med       Date:  1989-10-19       Impact factor: 91.245

3.  Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies.

Authors:  P Richardson; W McKenna; M Bristow; B Maisch; B Mautner; J O'Connell; E Olsen; G Thiene; J Goodwin; I Gyarfas; I Martin; P Nordet
Journal:  Circulation       Date:  1996-03-01       Impact factor: 29.690

4.  Enteroviral protease 2A cleaves dystrophin: evidence of cytoskeletal disruption in an acquired cardiomyopathy.

Authors:  C Badorff; G H Lee; B J Lamphear; M E Martone; K P Campbell; R E Rhoads; K U Knowlton
Journal:  Nat Med       Date:  1999-03       Impact factor: 53.440

5.  Immunohistological changes in dilated cardiomyopathy induced by immunoadsorption therapy and subsequent immunoglobulin substitution.

Authors:  A Staudt; F Schäper; V Stangl; A Plagemann; M Böhm; K Merkel; G Wallukat; K D Wernecke; K Stangl; G Baumann; S B Felix
Journal:  Circulation       Date:  2001-06-05       Impact factor: 29.690

6.  Detection of adenoviral genome in the myocardium of adult patients with idiopathic left ventricular dysfunction.

Authors:  M Pauschinger; N E Bowles; F J Fuentes-Garcia; V Pham; U Kühl; P L Schwimmbeck; H P Schultheiss; J A Towbin
Journal:  Circulation       Date:  1999-03-16       Impact factor: 29.690

7.  A clinical trial of immunosuppressive therapy for myocarditis. The Myocarditis Treatment Trial Investigators.

Authors:  J W Mason; J B O'Connell; A Herskowitz; N R Rose; B M McManus; M E Billingham; T E Moon
Journal:  N Engl J Med       Date:  1995-08-03       Impact factor: 91.245

8.  Clinical and prognostic significance of detection of enteroviral RNA in the myocardium of patients with myocarditis or dilated cardiomyopathy.

Authors:  H J Why; B T Meany; P J Richardson; E G Olsen; N E Bowles; L Cunningham; C A Freeke; L C Archard
Journal:  Circulation       Date:  1994-06       Impact factor: 29.690

9.  Myocardial enterovirus infection with left ventricular dysfunction: a benign disease compared with idiopathic dilated cardiomyopathy.

Authors:  H R Figulla; M Stille-Siegener; G Mall; A Heim; H Kreuzer
Journal:  J Am Coll Cardiol       Date:  1995-04       Impact factor: 24.094

10.  Ongoing enterovirus-induced myocarditis is associated with persistent heart muscle infection: quantitative analysis of virus replication, tissue damage, and inflammation.

Authors:  K Klingel; C Hohenadl; A Canu; M Albrecht; M Seemann; G Mall; R Kandolf
Journal:  Proc Natl Acad Sci U S A       Date:  1992-01-01       Impact factor: 11.205

  10 in total
  2 in total

1.  Oral tolerization with cardiac myosin peptide (614-629) ameliorates experimental autoimmune myocarditis: role of STAT 6 genes in BALB/CJ mice.

Authors:  Patricia A Gonnella; Pedro J Del Nido; Francis X McGowan
Journal:  J Clin Immunol       Date:  2009-04-08       Impact factor: 8.317

2.  5' terminal deletions in the genome of a coxsackievirus B2 strain occurred naturally in human heart.

Authors:  Nora M Chapman; Kyung-Soo Kim; Kristen M Drescher; Kuniyuki Oka; Steven Tracy
Journal:  Virology       Date:  2008-04-01       Impact factor: 3.616

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.